FEATURES OF THE MECHANISMS OF FORMATION OF PLEURAL EFFUSION IN PATIENTS WITH CORONARY HEART DISEASE IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION AND WAYS OF CORRECTION (THE REVIEW OF THE LITERATURE)

1. Diseases of the respiratory system / Ed. N.R. Paleev. Moscow: Meditsina, 1990. 726 p. [In Russian].
2. Deineka K.S. Laparoscopic mobilization of the arterial blood vessels for minimally invasive myocardial revascularization: Anatomic-experimental study: abstract of thesis…candidate of medical sciences. Moscow, 2000. [In Russian].
3. Zhbanov I.V., Molochkov A.V., Shabalkin B.V. Risk factors and the results of myocardial revascularization in elderly patients // Klinicheskaya gerontologiya = Clinical gerontology. 2007. 13. (5). 44-47. [In Russian].
4. Zhirov I.V., Goryunova T.V., Osmolovskaya Y.F., Tereshchenko S.N. Prolonged-release torasemide in patients with chronic heart failure // Effektivnaya farmakoterapiya = Effective pharmacotherapy. 2014. (25). 18–23. [In Russian].
5. Igolnikova L.N., Nikulina E. G. Postpericardiotomy syndrome: clinical and laboratory diagnosis, treatment (review) // Kardiologiya i serdechno-sosudistaya khirurgiya = Cardiology and Cardiovascular Surgery. 2012. (1). 42-46. [In Russian].
6. Maskell N.A., Butland R.J.A. The recommendations of the British Thoracic Society (BTS) survey of adult patients with unilateral pleural effusion // Pul'monlogiya = Pulmonology. 2006. (2). 13-26. [In Russian].
7. Matveeva G.V., Golovkin A.S., Grigor'ev E.V. et al. Dynamics of pro- and anti-inflammatory cytokines in the early postoperative period of coronary bypass surgery // Meditsinskaya immunologiya = Medical Immunology. 2011. 13. (4-5). 486. [In Russian].
8. Mayansky D.N. Chronic inflammation. Moscow: Meditsina, 1991. [In Russian].
9. Nikolaeva A.A., Nikolayev K.Yu., Oteva E.V. et al. Diagnostic technology in the clinical examination and the primary prevention of chronic non-communicable diseases // Zdravookhraneniye Rossiyskoy Federatsii = Health Care of the Russian Federation. 2004. (2). 55-56. [In Russian].
10. Oteva E.A., Nikolaeva A.A., Egorova N.A. et al. Approaches to primary prevention of cardiovascular diseases // Zdravookhraneniye Rossiyskoy Federatsii = Health Care of the Russian Federation. 2002. (1). 21-23. [In Russian].
11. Preobrazhensky D.V., Sidorenko B.A., Marenych A.V., Shatunova I.M. Diuretics in the treatment of arterial hypertension // Consilium Provisorum. 2002. 2. (1). 30-34. [In Russian].
12. Sovalkin V. I., Podgurskaya E. P. Differential diagnosis of pleural effusions // Omskiy nauchnyy vestnik = Omsk scientific journal. 2006. (3). 248-251. [In Russian].
13. Chechetkin A.V., Nikolaeva O.A., Volkov M.A., Zhiburt E.B. Immunological disorders in patients in the surgical treatment of ischemic heart disease // Vestnik khirurgii = Journal of surgery. 2002. (2). 106-110. [In Russian].
14. Chuchalin A.G. Pleura: clinical and pathophysiological aspects // Terapevticheskiy arkhiv = Therapeutic archive. 1999. (3). 5-9. [In Russian].
15. Shabalkin B.V. Formation and development of coronary surgery // Br Grudnaya i serdechno-sosudistaya khirurgiya = Russian Journal of Thoracic and Cardiovascular Surgery. 2001. (2). 4-7. [In Russian].
16. Shlyakhto E.V., Mareev V.Yu., Ageev F.T. et al. National recommendations PRAS cardiology and internal medicine on the diagnosis and treatment of chronic heart failure (fourth revision) // Serdechnaya nedostatochnoct' = Russian Heart Failure Journal. 2013. 14. (7). 379-472. [In Russian].
17. Shumakov V.I., Suskova V.S., Ermakova L.P. et al. Immune system in cardiac surgery patients with extracorporeal circulation // Vestnik transplantologii i iskusstvennykh organov = Russian Journal of Transplantology and Artificial Organs. 2003. (3). 41-45. [In Russian].
18. Ahmed A., Husain A., Love T.E. et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods // Eur. Heart J. 2006. 27. (12). 1431–1439.
19. Busekova E., Simkova I., Hulman M. Postpericardiotomy syndrome – post-cardiac injury syndrome // Bratisl. Lek. Listy. 2012. 113. (8). 481–485.
20. Edwards F.H., Clark R.E., Schwartz M. Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience // Ann. Thorac. Surg. 1994. 57. (1). 12-19.
21. Friedel H.A., Buckley M.M. Torasemide. A review of its pharmacological properties and therapeutic potential // Drugs. 1991. 41. (1). 81–103.
22. Fromes Y.,Gaillard D., Ponzio O. et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation // Eur. J. Cardiothor. Surg. 2002. 22. (4). 527—533.
23. Ringleb P.A., Bousser M.G., Ford G. et al. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack – 2008 // Cerebrovasc. Dis. 2008. 25. (5). 457–507.
24. Tzoulaki I., Murray G.D., Lee A.J. et al. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study // Circulation. 2005. 112. (7). 976-983.
25. Wang J., Zheng Z., Yang L. et al. High-sensitive C-reactive protein predicts outcome after coronary artery bypass // Asian Cardiovasc. Thorac. Ann. 2012. 20. (5). 525-533.
26. Weissman C. Pulmonary complications after cardiac surgery // Semin. Cardiothorac. Vasc. Anesth. 2004. 8. (3). 185-211.

Skripkina N.V. – cardiologist, postgraduate student of department of pathological physiology, e-mail: scripcina-natasha@rambler.ru